1. Abalovich M, Amino N, Barbour LA, Cobin RH, De Groot L, Glinoer D, Mandel SJ, Stagnaro-Green A: Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 92: In press, August 2007
2. Dworkin HJ, Jacquez JA, Beierwaltes WH: Relationship of iodine ingestion to iodine excretion in pregnancy. J Clin Endocrinol Metab 26:1329, 1966
3. Glinoer D, De Nayer P, Bourdoux, et al: Regulation of maternal thyroid function during pregnancy. J Clin Endocrinol Metab 71:276, 1990
4. Glinoer D, Delange F, Laboureur I, De Nayer P: Maternal and neonatal thyroid function at birth in an area with of marginally low iodine intake. J Clin Endocrinol Metab 75:800, 1992
5. Burrow GN: Thyroid function and hyperfunction during gestation. Endocr Rev 14:194, 1993
6. Glinoer D: The regulation of thyroid function in pregnancy: Pathways of endocrine adaptation from physiology to pathology. Endocr Rev 18:404, 1997
7. Liberman CS, Pino SC, Lieh Fang S, Braverman LE, Emerson CH: Circulating iodide concentrations during and after pregnancy. J Clin Endocrinol Metab 83:3545, 1998
8. Halnan KE: The radioiodine uptake of the human thyroid in pregnancy. Clin Sci 17:281, 1958
9. Crooks J, Tulloch MI, Turnbull AC, et al: Comparative incidence of goitre in pregnancy in Iceland and Scotland. Lancet 2:625, 1969
10. Glinoer D, Lemone M: Goiter and pregnancy: a new insight into an old problem. Thyroid 2:65, 1992
11. Glinoer D, De Nayer P, Delange F, et al: A randomized trial for the treatment of mild iodine deficiency during pregnancy: maternal and neonatal effects. J Clin Endocrinol Metab 80:258, 1995
12. Levy RP, Newman DM, Rejali LS, Barford DA: The myth of goiter in pregnancy. Am J Obstet Gynecol 137:701, 1980
13. Nelson M, Wickus GG, Caplan RH, Beguin EA: Thyroid gland size in pregnancy: an ultrasound and clinical study. J Reproduct Med 32:888, 1987
14. Hershman JM: Physiological and pathological aspects of the effect of human chorionic gonadotropin on the thyroid. In: Best Practice & Research in Clinical Endocrinology and Metabolism: The Thyroid and Pregnancy (Editor: Glinoer D) 18:249, 2004
15. Merz WE: Biosynthesis of human chorionic gonadotropin: a review. Eur J Endocrinol 135:269, 1996
16. Smits G, Govaerts C, Nubourgh I, Pardo L, Vassart G, Costagliola S: Lysine 183 and glutamic acid 157 of the TSH receptor: two interacting residues with a key role in determining specificity toward TSH and human CG. Molec Endocrinol 16:722, 2002
17. Hershman JM, Lee HY, Sugawara M, et al: Human chorionic gonadotropin stimulates iodide uptake, adenylate cyclase, and deoxyribonuceic acid synthesis in cultured rat thyroid cells. J Clin Endocrinol Metab 67:74, 1988
18. Hershman JM: Role of human chorionic gonadotropin as a thyroid stimulator. J Clin Endocrinol Metab 74:258, 1992
19. Pekonen F, Alfthan H, Stenman UH, Ylikorkala O: Human chorionic gonadotropin (hCG) and thyroid function in early pregnancy: Circadian variation and evidence for intrinsic thyrotropic activity of hCG. J Clin Endocrinol Metab 66:853, 1988
20. Harada A, Hershman JM, Reed AW, et al: Comparison of thyroid stimulators and thyroid hormone concentrations in the sera of pregnant women. J Clin Endocrinol Metab 48:793, 1979
21. Kimura M, Amino N, Tamaki H, et al: Physiologic thyroid activation in normal early pregnancy is induced by circulating hCG. Obstet Gynecol 75:775, 1990
22. Arturi F, Presta I, Scarpelli D, et al: Stimulation of iodide uptake by human chorionic gonadotropin in FRTL-5 cells: effects on sodium/iodide symporter gene and protein expression. Eur J Endocrinol 147:655, 2002
23. Ballabio M, Poshyachinda M, Ekins RP: Pregnancy-induced changes in thyroid function: Role of human chorionic gonadotropin as putative regulator of maternal thyroid. J Clin Endocrinol Metab 73:824, 1991
24. Glinoer D, De Nayer P, Robyn C, et al: Serum levels of intact human chorionic gonadotropin (hCG) and its free alpha and beta subunits, in relation to maternal thyroid stimulation during normal pregnancy. J Endocrinol Invest 16:881, 1993
25. Guillaume J, Schussler GC, Goldman J: Components of the total serum thyroid hormone concentrations during pregnancy: high free thyroxine and blunted thyrotropin (TSH) response to TSH-releasing hormone in the first trimester. J Clin Endocrinol Metab 60:678, 1985
26. Weeke J, Dykbjaer L, Granlie K, et al: A longitudinal study of serum TSH, and total and free iodothyronines during normal pregnancy. Acta Endocrinol 101:531, 1982
27. Chan BY, Swaminathan R: Serum thyrotropin concentration measured by sensitive assays in normal pregnancy. Br J Obstet Gynaecol 95:1332, 1988
28. Yamamoto T, Amino N, Tanizawa O, et al: Longitudinal study of serum thyroid hormones, chorionic gonadotrophin during and after normal pregnancy. Clin Endocrinol 10:459, 1979
29. Ylikorkala O, Kivinen S, Reinila MI: Serial prolactin and thyrotropin responses to thyrotropin-releasing hormone throughout normal human pregnancy. J Clin Endocrinol Metab 48:288, 1979
30. Yoshikawa N, Nishikawa M, Horimoto M, et al: Thyroid-stimulating activity in sera of normal pregnant women. J Clin Endocrinol Metab 69:891, 1989
31. Pacchiarotti A, Martino E, Bartalena L, et al: Serum thyrotropin by ultrasensitive immunoradiometric assay and serum free thyroid hormones in pregnancy. J Endocrinol Invest 9:185, 1986
32. Glinoer D: The thyroid in pregnancy: a European perspective. Thyroid Today 18:1, 1995
33. Kraiem Z, Lahat N, Sadeh O, et al: Desialylated and deglycosylated human chorionic gonadotropin are superagonists of native human chorionic gonadotropin in human thyroid follicles. Thyroid 7:783, 1997
34. Norman RJ, Green-Thompson RW, Jialal I, et al: Hyperthyroidism in gestational trophoblastic neoplasia. Clin Endocrinol 15:395, 1981
35. Nagataki S, Mizuno M, Sakamoto S, et al: Thyroid function in molar pregnancy. J Clin Endocrinol Metab 44:254, 1977
36. Berghout A, Endert E, Wiersinga WM, Touber JL: The application of an immunoradiometric assay of plasma thyrotropin (TSH-IRMA) in molar pregnancy. J Endocrinol Invest 11:15, 1988
37. Verberg MF, Gillott DJ, Al-Fardan N, Grudzinskas JG: Hyperemesis gravidarum, a literature review. Hum Reprod Update 11:527, 2005
38. Al-Yatama M, Diejomaoh M, Nandakumaran M, et al: Hormone profile of Kuwaiti women with hyperemesis gravidarum. Arch Gynecol Obstet 266:218, 2002
39. Tan JY, Loh KC, Yeo GS, Chee YC: Transient hyperthyroidism of hyperemesis gravidarum. Brit J Obstet Gynaecol 109:683, 2002
40. Kirshon B, Lee W, Cotton DB: Prompt resolution of hyperthyroidism and hyperemesis gravidarum after delivery. Obstet Gynecol 71:1032, 1988
41. Goodwin TM, Montoro M, Mestman JH: Transient hyperthyroidism and hyperemesis gravidarum: clinical aspects. Am J Obstet Gynecol 167:648, 1992
42. Goodwin TM, Montoro M, Mestman JH: The role of chorionic gonadotropin in transient hyperthyroidism of hyperemesis gravidarum. J Clin Endocrinol Metab 75:1333, 1992
43. Lao TT, Chin KH, Chang AMZ: The outcome of hyperemetic pregnancies complicated by transient hyperthyroidism. Aust NZ J Obstet Gynaecol 27:99, 1987
44. Dozeman R, Kaiser FE, Cass O, Pries J: Hyperthyroidism appearing as hyperemesis gravidarum. Arch Int Med 143:2202, 1983
45. Goodwin TM, Hershman JM: Hyperthyroidism due to inappropriate production of human chorionic gonadotropin. Clin Obstet Gynecol 40:32, 1997
46. Glinoer D: Thyroid hyperfunction during pregnancy. Thyroid 8:859, 1998
47. Mori M, Amino N, Tamaki H, et al: Morning sicknesss and thyroid function in normal pregnancy. Obstet Gynecol 72:355, 1988
48. Bouillon R, Naessens M, Van Assche FA, et al: Thyroid function in patients with hyperemesis gravidarum. Am J Obstet Gynecol 143:922, 1982
49. Yoshimura M, Hershman JM, Pang XP, Berg L, Pekary AE: Activation of the thyrotropin (TSH) receptor by human chorionic gonadotropin and luteinizing hormone in Chinese hamster ovary cells expressing functional human TSH receptors. J Clin Endocrinol Metab 77:1009, 1993
50. Yoshimura M, Hershman JM: Thyrotropic action of human chorionic gonadotropin. Thyroid 5:425, 1995
51. Jordan V, Grebe SK, Cooke RR, et al: Acidic forms of chorionic gonadotrophin in European and Samoan women are associated with hyperemesis gravidarum and may be thyrotrophic. Clin Endocrinol 50:619, 1999
52. Glinoer D, Gershengorn MC, Dubois A, et al: Stimulation of thyroxine-binding globulin synthesis by isolated rhesus monkey hepatocytes after in vivo -estradiol administration. J Clin Endocrinol Metab 100:807, 1977
53. Ain KB, Mori Y, Refetoff S: Reduced clearance rate of thyroxine-binding globulin (TBG) with increased sialylation: a mechanism for estrogen-induced elevation of serum TBG concentration. J Clin Endocrinol Metab 65:689, 1987
54. Ain KB, Refetoff S: Relationship of oligosaccharide modification to the cause of serum thyroxine-binding globulin excess. J Clin Endocrinol Metab 66:1037, 1988
55. Refetoff S: Inherited thyroxine-binding globulin abnormalities in man. Endocr Rev 10:275, 1989
56. Bartalena L: Recent achievements in studies on thyroid hormone-binding proteins. Endocr Rev 11:47, 1990
57. Zigman JM, Cohen SE, Garber JR: Impact of thyroxine-binding globulin on thyroid hormone economy during pregnancy. Thyroid 13:1169, 2003
58. Glinoer D: Increased TBG during pregnancy and increased hormonal requirements. Thyroid (letter to the Editor) 14:179, 2004
59. Burrow GN, Fisher DA, Larsen PR: Mechanisms of disease: Maternal and fetal thyroid function. N Engl J Med 331:1072, 1994
60. Mandel SJ, Larsen PR, Seely EW: Increased need for thyroxine during pregnancy in women with primary hypothyroidism. N Eng J Med 323:91, 1990
61. Kaplan MM: Monitoring thyroxine treatment during pregnancy. Thyroid 2:147, 1992
62. Larsen PR: Monitoring thyroxine treatment during pregnancy. Thyroid 2:153, 1992
63. Dowling JT, Appleton WG, Nicoloff JT: Thyroxine turnover during human pregnancy. J Clin Endocrinol Metab 27:1749, 1964
64. Smallridge RC, Glinoer D, Hollowell JG, Brent G: Thyroid function inside and outside of pregnancy: what do we know and what don’t we know? Thyroid 15:54, 2005
65. Demers LM, Spencer CA: Laboratory support for the diagnosis and monitoring of thyroid disease. Website of the National Academy of Clinical Biochemistry. NACB laboratory medicine practice guidelines ( http://www.nacb.org/lmpg/main.stm)
66. Soldin OP, Tractenberg RA, Hollowell JG, et al: trimester-specific changes in maternal thyroid hormone, thyrotropin and thyroglobulin concentrations during pregnancy – Trends and associations across trimesters in iodine sufficiency. Thyroid 14:1084, 2004
67.Kahric-Janicic N, Soldin SJ, Soldin OP, West T, Gu J, Jonklaas J: Tandem mass spectrometry improves the accuracy of free thyroxine measurements during pregnancy. Thyroid 17:303, 2007
68. Osathanondh R, Tulchinsky D, Chopra IJ: Total and free thyroxine and triiodothyronine in normal and complicated pregnancy. J Clin Endocrinol Metab 42:98, 1976
69.Sapin R, D’Herbomez M, Schlienger JL: Free thyroxine measured with equilibrium dialysis and nine immunoassays decreases in late pregnancy. Clin Lab 50:581, 2004
70.Baloch Z, Carayon P, Conte-Devolx B, Demers LM, Feldt-Rasmussen U, Henry JF, LiVosli VA, Niccoli-Sire P, John R, Ruf J, Smyth PP, Spencer CA, Stockigt JR: Laboratory medicine practice guidelines: laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 13:3, 2003
71.Kurioka H, Takahashi K, Miyazaki K: Maternal thyroid function during pregnancy and puerperal period. Endocrine J 52:587, 2005
72. Panesar NS, Li CY, Rogers MS: Reference intervals of thyroid hormones in pregnant Chinese women. Ann Clin Biochem 38:329, 2001
73. Haddow JE, Knight GJ, Palomaki GE, et al: The reference range and within-person variability of thyroid stimulating hormone during the first and second trimesters of pregnancy. J Med Screen 11:170, 2004
74. Dashe JS, Casey BM, Wells CE, McIntire DD, Byrd EW, Leveno KJ, Cunningham FG: Thyroid stimulating hormone in singleton and twin pregnancy: importance of gestational age-specific reference ranges. Obstet Gynecol 106:753, 2005
75. Roti E, Fang SL, Green K, et al: human placenta is an active site of thyroxine and 3,3',5-triiodothyronine tyrosyl ring deiodination. J Clin Endocrinol Metab 53:498, 1981
76. Roti E, Gnudi A, Braverman LE: The placental transport, synthesis and metabolism of hormones and drugs which affect thyroid function. Endocr Rev 4:131, 1983
77. Hidal JT, Kaplan MM: Characteristics of thyroxine 5'-deiodination in cultured human placental cells. J Clin Invest 76:947, 1985
78. Burman KD, Read J, Dimond RC, et al: Measurements of 3,3',5'-triiodothyronine (reverse T3), 3,3'-L-diiodothyronine, T3, and T4 in human amniotic fluid and in cord and maternal serum. J Clin Endocrinol Metab 43:1351, 1976
79. El-Zaheri MM, Vagenakis AG, Hinerfeld L, et al: Maternal thyroid function is the major determinant of amniotic fluid 3,3',5'-triiodothyronine in the rat. J Clin Invest 67:1126, 1981
80. Landau H, Sack J, Frucht H, et al: Amniotic fluid 3,3',5'-triiodothyronine in the detection of congenital hypothyroidism. J Clin Endocrinol Metab 50:799, 1980
81. Meinhold H, Dudenhausen JW, Wenzel KW, Saling E: Amniotic fluid concentrations of 3,3',5'-triiodothyronine (reverse T3), 3,3'-diiodothyronine, 3,5,3'-triiodothyronine (T3) and thyroxine (T4) in normal and complicated pregnancy. Clin Endocrinol 10:355, 1979
82. Vulsma T, Gons MH, De Vijlder JMM: Maternal fetal transfer of thyroxine in congenital hypothyroidism due to a total organification defect of thyroid dysgenesis. N Engl J Med 321:13, 1989
83. Contempre B, Jauniaux E, Calvo R, et al: Detection of thyroid hormones in human embryonic structures during the first trimester of pregnancy. J Clin Endocrinol Metab 77:1719, 1993
84. Calvo RM, Jauniaux E, Gulbis B, et al: Fetal tissues are exposed to biologically relevant free thyroxine concentrations during early phases of development. J Clin Endocrinol Metab 87:1768, 2002
85. Glinoer D, Delange F: The potential repercussions of maternal, fetal, and neonatal hypothyroxinemia on the progeny. Thyroid 10:871, 2000
86. Morreale de Escobar G, Obregon MJ, Escobar del Rey F: Is neuropsychological development related to maternal hypothyroidism or to maternal hypothyroxinemia? J Clin Endocrinol Metab 85:3975, 2000
87. Glinoer D: The thyroid gland and pregnancy: Iodine restriction and goitrogenesis revealed. Thyroid International 5:1, 1994
88. Glinoer D: Maternal and fetal impact of chronic iodine deficiency. Clin Obstet Gynecol 40:102, 1997
89. Glinoer D: Maternal and neonatal thyroid function in mild iodine deficiency. In: Nauman J, Glinoer D, Braverman LE, Hostalek U (Editors). The Thyroid and Iodine. Stuttgart, New York, Schattauer, pp 129-143, 1996
90. Glinoer D: Pregnancy and iodine. Thyroid 11:471, 2001
91. WHO: Assessment of iodine deficiency disorders and monitoring their elimination: a guide for programme managers. Second Edition, 2001
92.ICCIDD: Iodine requirements in pregnancy and infancy. IDD Newsletter 23 (N°1), 1-2, 2007
93. Glinoer D: The importance of iodine nutrition during pregnancy. Public Health Nutrition 2007 (in press)
94.WHO: Technical Consultation of experts in Geneva in January 2005. The prevention and control of iodine deficiency in pregnant and lactating women and in children under two years: recommendations of a WHO Technical Consultation. Public Health Nutrition 2007 (in press)
95. Caron P, Hoff M, Bazzi S, et al: Urinary iodine excretion during normal pregnancy in healthy women living in the southwest of France: correlation with maternal thyroid parameters. Thyroid 7:749, 1997
96. Kung AWC, Lao TT, Chau MT, Tam SCF, Low LCK: Goitrogenesis during pregnancy and neonatal hypothyroxinemia in a borderline iodine sufficient area. Clin Endocrinol 53:725, 2000
97. Nohr SB, Laurberg P, Borlum K-G, et al: Iodine deficiency in pregnancy in Denmark: regional variations and frequency of individual iodine supplementation. Acta Obstet Gynecol Scand 72:350, 1993
98. Smyth PP, Hetherton AM, Smith DF, Radcliff M, O'Herlihy C: Maternal iodine status and thyroid volume during pregnancy: correlation with neonatal iodine intake. J Clin Endocrinol Metab 82:2840, 1997
99. Vermiglio F, Lo Presti VP, Castagna MG, et al: Increased risk of maternal thyroid failure with pregnancy progression in an iodine deficient area with major iodine deficiency disorders. Thyroid 9:19, 1999
100. Antonangeli L, Maccherini D, Cavaliere R, et al: Comparison of two different doses of iodide in the prevention of gestational goiter in marginal iodine deficiency: a longitudinal study. Eur J Endocrinol 147:29, 2002
101. Chaouki ML, Benmiloud: Prevention of iodine disorders by oral administration of lipiodol during pregnancy. Eur J Endocrinol 130:547, 1994
102.Liesenkotter KP, Gopel W, Bogner U, Stach B, Gruters A: Earliest prevention of endemic goiter by iodine supplementation during pregnancy. Eur J Endocrinol 134:443, 1996
103. Nohr SB, Laurberg P: Opposite variations in maternal and neonatal thyroid function induced by iodine supplementation during pregnancy. J Clin Endocrinol Metab 85:623, 2000
104. Pedersen KM, Laurberg P, Iversen E, et al: Amelioration of some pregnancy-associated variations in thyroid function induced by iodine supplementation. J Clin Endocrinol Metab 77:1078, 1993
105. Romano R, Jannini EA, Pepe M, et al: The effects of iodoprophylaxis on thyroid size during pregnancy. Am J Obstet Gynecol 164:482, 1991
106. Silva JE, Silva S: Interrelationships among thyroxine, triiodothyronine, reverse triiodothyronine, and thyroid-stimulating hormone in iodine-deficient pregnant women and their offspring: effects of iodine supplementation. J Clin Endocrinol Metab 52:671, 1981
107. Delange F, de Benoist B, Pretell E, Dunn J: Iodine deficiency in the world: where do we stand at the turn of the century. Thyroid 11:437, 2001
108. Delange F, Eastman CJ, Hostalek U, Butz S, Smyth PP: The story of the ThyroMobil. Thyroid International N°1, 3-13, 2007
109. Als C, Keller A, Minder C, Haldimann M, Gerber H: Age- and gender-dependent urinary iodine concentrations in an area-covering population sample from the Bernese region in Switzerland. Europ J Endocrinol 143:629, 2000
110. Brander L, Als C, Buess H, et al.: Urinary iodine concentration during pregnancy in an area of unstable dietary iodine intake in Switzerland. J Endocrinol Invest 26:389-396, 2003
111. Sack J, Goldstein A, Charpak N, et al.: Postpartum maternal hyperthyrotropinemia in an area in which iodine supplementation is required. Thyroid 13:959-964, 2003
112. Ciardelli R, Haumont D, Gnat D, et al: The nutritional iodine supply of belgian neonates is still insufficient. Europ J Pediatr 161:519, 2002
113.The Public Health Committee of the American Thyroid Association: Iodine supplementation for pregnancy and lactation – United States and Canada: recommendations of the American Thyroid Association. Thyroid 16:949, 2006
114. Hollowell JG, Staehling NW, Hannon WH, et al: Iodine nutrition in the United States. Trends and public health implications: iodine excretion data from national health and nutrition examination surveys I and III (1971-1974 and 1988-1994). J Clin Endocrinol Metab 83:3401, 1998
115. Caldwell JK, Jones R, Hollowell JG: Urinary iodine concentrations: United States National Health and Nutrition Examination Survey 2001-2002. Thyroid 15:692, 2005
116. Dunn JT: What is happening to our iodine (Editorial). J Clin Endocrinol Metab 83:3398, 1998
117. Dunn JT, Delange F: Damaged reproduction: the most important consequence of iodine deficiency. J Clin Endocrinol Metab 86:2360, 2001
118.Glinoer D (Guest Editorial): Iodine nutrition requirements during pregnancy. Thyroid 16:947, 2006
119. Sullivan KJ: Letter to the Editor. Thyroid 17:483, 2007
120.Glinoer D: The regulation of thyroid function during normal pregnancy: importance of the iodine nutrition status. In: Best Practice & Research in Clinical Endocrinology and Metabolism: The Thyroid and Pregnancy (Editor: Glinoer D) 18:133, 2004
121. Glinoer D: Feto-maternal repercussions of iodine deficiency during pregnancy. Annales d’Endocrinologie (Paris) 64:37, 2003
122. Glinoer D: What happens to the normal thyroid during pregnancy? Thyroid 9:631, 1999
123. Brander A, Kivisaari L: Ultrasonography of the thyroid during pregnancy. J Clin Ultrasound 17:403, 1989
124. Glinoer D, Lemone M, Bourdoux P, et al: Partial reversibility during late postpartum of thyroid abnormalities associated with pregnancy. J Clin Endocrinol Metab 74:453, 1992
125. Rotondi M, Amato G, Biondi B, et al: Parity as a thyroid size-determining factor in areas with moderate iodine deficiency. J Clin Endocrinol Metab 85:4534, 2000
126. Knudsen N, Bülow I, Laurberg P, et al: Parity is associated with increased thyroid volume solely among smokers in an area with moderate to mild iodine deficiency. Europ J Endocrinology 146:39, 2002
127. Glinoer D, Demeester R, Lemone M, et al.: Acute increase in goiter size during a normal pregnancy: an exceptional case report. Thyroid 13:881, 2003
128. Delange F, Lecomte P: Iodine supplementation – Benefits outweigh risks. Drug Safety 2:89, 2000
129. de Benoist B, Delange F, Glinoer D, et al: Recommendations for the prevention and control of iodine deficiency in pregnant and lactating women and in children less than two years old. Public Health Nutrition (in press), 2007
130. Delange F, Benker G, Caron P, et al: Thyroid volume and urinary iodine in European schoolchildren: standardization of values for assessment of iodine deficicency. Europ J Endocrinol 136:180, 1997
131. Delange F, Van Onderbergen A, Shabana W, et al: Silent iodine prophylaxis in Western Europe only partly corrects iodine deficiency: the case of Belgium. Europ J Endocrinol 143:189, 2000
132. Ivanova RB, Kirilov G, Ivanova LB, Lozanov BS: Evaluation of the thyroid status of pregnant women under supplementation with iodized salt. J Endocrinol Invest 25 (suppl. to N° 7):91, 2002
133. Delange F, Bürgi H, Chen ZP, Dunn JT: World status of monitoring of iodine deficiency disorders control programs. Thyroid 12:915, 2002
134. Dunn JT: The use of iodized oil and other alternatives for the elimination of iodine deficiency disorders. In: the Conquest of Iodine Deficiency Disorders (Hetzel BS, Pandav CS, Editors). New Delhi: Oxford University Press Publications; pp 108-117, 1994
135. Thilly CH, Delange F, Lagasse R, et al: Fetal hypothyroidism and maternal thyroid status in severe endemic goiter. J Clin Endocrinol Metab 47:354, 1978
136. Delange F: Optimal iodine nutrition during pregnancy, lactation and the neonatal period. Int J Endocrinol Metab 2:1, 2004
137. Zimmermann MB, Aeberli I, Torresani T, Bürgi H: a small increase in salt iodination improves iodine nutrition in children and pregnant women. Am J Clin Nutrition 82:388, 2005
138. Andersson M, Takkouche B, Egli I, et al: Current global iodine status and progress over the last decade towards the elimination of iodine deficiency. Bull WHO 83:518, 2005
139. Imaizumi M, Pritzker A, Kita M, et al: Pregnancy and murine thyroiditis: thyroglobulin immunization leads to fetal loss in specific allogeneic pregnancies. J Clin Endocrinol Metab 142:823, 2001
140. Sridama V, Pagini F, Yang SL, et al: Decreased level of helper T cells: a possible cause of immunodeficiency in pregnancy. N Engl J Med 307:352, 1982
141. Stagnaro-Green A, Roman SH, Cobin RH, et al: A prospective study of lymphocyte-initiated immunosuppression in normal pregnancy: evidence of a T-cell etiology for postpartum dysfunction. J Clin Endocrinol Metab 74:645, 1992
142. Bech K, Hoier-Madsen M, Feldt-Rasmussen U, et al: Thyroid function in insulin-dependent diabetes mellitus during and after pregnancy. Acta Endocrinol 124:534, 1991
143. DeGroot LJ, Quintans J: The causes of autoimmune thyroid disease. Endocr Rev 10:537, 1989
144. Amino N, Miayi K, Onishi T, et al: Transient hypothyroidism after delivery in autoimmune thyroiditis. J Clin Endocrinol Metab 42:296, 1976
145. Amino N, Miayi K, Kuro R, et al: Transient postpartum hypothyroidism: fourteen cases with autoimmune thyroiditis. Ann Intern Med 87:155, 1977
146. Amino N, Mori H, Iwatani Y, et al: High prevalence of transient post-partum thyrotoxicosis and hypothyroidism. N Engl J Med 306:849, 1982
147. Jansson R, Bernander S, Karlsson A, et al: Autoimmune thyroid dysfunction in the postpartum period. J Clin Endocrinol Metab 58:681, 1984
148. Bech K, Hertel J, Rasmussen NG, et al: Effect of maternal thyroid autoantibodies and post-partum thyroiditis on the fetus and neonate. Acta Endocrinol 125:146, 1991
149. McKenzie JM, Zakarija M: The clinical use of thyrotropin receptor antibody measurements. J Clin Endocrinol Metab 69:1093, 1989
150. Mc Kenzie JM, Zakarija M: Fetal and neonatal hyperthyroidism and hypothyroidism due to maternal TSH receptor antibodies. Thyroid 2:155, 1992
151. Roti E, Emerson CH: Postpartum thyroiditis. J Clin Endocrinol Metab 74:3, 1992
152. Rasmussen NG, Hornnes PJ, Hoier-Madsen M, et al: Thyroid size and function in healthy pregnant women with thyroid autoantibodies: Relation to development of postpartum thyroiditis. Acta Endocrinol 123:395, 1990
153. Zakarija M, McKenzie JM: Pregnancy-associated changes in the thyroid-stimulating antibody of Graves' disease and the relationship to neonatal hyperthyroidism. J Clin Endocrinol Metab 57:1036, 1983
154. Jansson R, Totterman TH, Sallstrom J, Dahlberg PA: Intrathyroidal and circulating lymphocyte subsets in different stages of autoimmune postpartum thyroiditis. J Clin Endocrinol Metab 58:942, 1984
155. Thonneau P, Marchand S, Tallec A, et al: Incidence and main causes of infertility in a resident population (1.850.000) of three French regions (1988-1989). Hum Reprod 6:811, 1991
156. Dosiou C, Giudice LC: Natural killer cells in pregnancy and recurrent pregnancy loss: endocrine and immunologic perspectives. Endocrine Rev 26:44, 2005
157. Poppe K, Velkeniers B: Female infertility and the thyroid. In: Best Practice & Research in Clinical Endocrinology and Metabolism: The Thyroid and Pregnancy (Editor: Glinoer D) 18:153, 2004
158. Poppe K, Glinoer D, Van Steirteghem A, et al: Thyroid dysfunction and autoimmunity in infertile women. Thyroid 12:997, 2002
159. Poppe K, Glinoer D, Tournaye H, et al: Assisted reproduction and thyroid immunity: an unfortunate combination? J Clin Endocrinol Metab 88:4149, 2003
160. Poppe K, Glinoer D, Van Steirteghem A, et al: Increased thyroid autoimmunity but not thyroid dysfunction in infertile women. A comment by Utiger RD in Clinical Thyroidology 15:2, 2003
161.Poppe K, Velkeniers B, Glinoer D: Thyroid disease and female reproduction. Clin Endocrinol 66:309, 2007
162. Trummer H, Ramschak-Schwarzer S, Haas J, et al: Thyroid hormones and thyroid antibodies in infertile males. Fertil Steril 76:254, 2001
163. Krassas GE, Perros P: Thyroid disease and male reproductive function. J Endocrinol Invest 26:372, 2003
164. Krassas GE, Pontikides N: Male reproductive function in relation with thyroid alterations. In: Best Practice & Research in Clinical Endocrinology and Metabolism: The Thyroid and Pregnancy (Editor: Glinoer D) 18:183, 2004
165. Wilcox AJ, Weinberg CR, O’Conner JF, et al: Incidence of early loss of pregnancy. N Engl J Med 319:189, 1988
166. Fausett MB, Branch DW: Autoimmunity and pregnancy loss. Sem Reprod Med 18:379, 2000
167. Li TC, Makris M, Tomsu M, et al: Recurrent miscarriage: aetiology, management and prognosis. Eur Soc Hum Reprod Embryol 8:463, 2002
168. Stagnaro-Green A, Roman SH, Cobin RH, et al: Detection of at-risk pregnancy by means of highly sensitive assays for thyroid antibodies. JAMA 264:1422, 1990
169. Glinoer D, Fernandez Soto ML, Bourdoux P, et al: Pregnancy in patients with mild thyroid abnormalities: Maternal and neonatal repercussions. J Clin Endocrinol Metab 73:421, 1991
170. Poppe K, Glinoer D: Thyroid autoimmunity and hypothyroidism before and during pregnancy. Hum Reprod Update 9:149, 2003
171. Stagnaro-Green A, Glinoer D: Thyroid autoimmunity and the risk of miscarriage. In: Best Practice & Research in Clinical Endocrinology and Metabolism: The Thyroid and Pregnancy (Editor: Glinoer D) 18:167, 2004
172. Prummel MF, Wiersinga WM: Thyroid autoimmunity and miscarriage. Europ J Endocrinol 150:751, 2004
173. Muller AF, Verhoeff A, Mantel MJ, Berghout A: Thyroid autoimmunity and abortion : a prospective study in women undergoing in vitro fertilization. Fertil Steril 71:30, 1999
174. Abramson J, Stagnaro-Green A: Thyroid antibodies and fetal loss: an evolving story. Thyroid 11:57, 2001
175. Matalon ST, Blank M, Ornoy A, Shoenfeld Y: The association between anti-thyroid antibodies and pregnancy loss. Am J Reprod Immunol 45:72, 2001
176. Bussen S, Steck T, Dietl J: Increased prevalence of thyroid antibodies in women with a history of recurrent in-vitro fertilization failure. Human Reprod 15:545, 2000
177. Dendrinos S, Papasteriades C, Tarassi K, et al: Thyroid autoimmunity in patients with recurrent spontaneous abortion. Gynecol Endocrinol 14:270, 2000
178. Glinoer D: Thyroid immunity, thyroid dysfunction, and the risk of miscarriage (Editorial). Amer J Reprod Immunol 43:202, 2000
179. Netto S, Medina Coeli C, et al: Thyroid autoimmunity is a risk factor for miscarriage. Am J Reprod Immunol 52:312, 2004
180.Kim CH, Chae HD, Kang BM, Chang YS: Influence of antithyoid antibodies in euthyroid women on in vitro fertilization embryo transfer outcome. Am J Reprod Immunol 40:2, 1998
181.Negro R, Mangieri T, Coppola L, et al.: Levothyroxine treatment in thyroid peroxidase antibody-positive women undergoing assisted reproduction technologies: a prospective study. Hum Reprod 20:1529, 2005
182.Singh A, Dantas ZN, Stone SC, et al.: Presence of thyroid antibodies in early reproductive failure: biochemical versus clinical pregnancies. Fertil Steril 63:277, 1995
183.Kutteh WH, Schoolcraft WB, Scott RT Jr: Antithyroid antibodies do not affect pregnancy outcome in women undergoing assisted reproduction. Hum Reprod 14:2886, 1999
184.Kutteh WH, Yetman DL, Carr AC, et al.: Increased prevalence of antithyroid antibodies identified in women with recurrent pregnancy loss but not in women undergoing assisted reproduction. Fertil Steril 71:843, 1999
185.Geva E, Vardinon N, Lessing JB, et al.: Organ-specific autoantibodies are possible markers for reproductive failure: a prospective study in an in-vitro fertilization-embryo transfer programme. Hum Reprod 11:1627, 1996
186. Kiprov DD, Nachtigall RD, Weaver RC, et al: The use of intravenous immunoglobulin in recurrent pregnancy loss associated with combined alloimmune and autoimmune abnormalities. Am J Reprod Immunol 36:228, 1996
187. Sher G, Zouves C, Feinman M, et al: The use of combined heparin/aspirin and immunoglobulin G therapy in the treatment of in vitro fertilization patients with antithyroid antibodies. Am J Reprod Immunol 39:223, 1998
188. Stricker RB, Steinleitner A, Bookoff CN, et al: Successful treatment for immunological abortion with low-dose intravenous immunoglobulin. Fertil Steril 73:536, 2000
189. Vaquero E, Lazzarin N, De Carolis C, et al: Mild thyroid abnormalities and recurrent spontaneous abortion: diagnostic and therapeutic approach. Amer J Reprod Immunol 43:204, 2000
190.Negro R, Formoso G, Mangieri T, Pezzarossa A, et al: Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: effects on obstetrical complications. J Clin Endocrinol Metab 91:2587, 2006
191.Glinoer D: Miscarriage in women with positive anti-TPO antibodies: is thyroxine the answer (Editorial). J Clin Endocrinol Metab 91:2500, 2006
192. Arojoki M, Jokimaa V, Juuti A, et al: Hypothyroidism among infertile women in Finland. Gynecol Endocrinol 14:127, 2000
193. Vanderpump MP, Tunbridge WM, French JM, et al: The incidence of thyroid disorders in a community: a twenty-year follow-up of the Whickam survey. Clin Endocrinol 43:55, 1995
194. Glinoer D: The systematic screening and management of hypothyroidism and hyperthyroidism during pregnancy. Trends Endocrinol Metab 9: 403, 1998
195. Gerstein HC: Incidence of postpartum thyroid dysfunction in patients with type I diabetes mellitus. Ann Intern Med 118:419, 1993
196. Olivieri A, Valensise H, Magnani F, et al: High frequency of antithyroid antibodies in pregnant women at increased risk of gestational diabetes mellitus. Europ J Endocrinol 143:741, 2000
197. Glinoer D, Rihai M, Grün JP, Kinthaert J: Risk of subclinical hypothyroidism in pregnant women with autoimmune thyroid disorders. J Clin Endocrinol Metab 79:197, 1994
198. Klein RZ, Haddow JE, Faix JD, et al: Prevalence of thyroid deficiency in pregnant women. Clin Endocrinol 35:41, 1991
199. Allan WC, Haddow JE, Palomaki GE, et al: Maternal thyroid deficiency and pregnancy complications: implications for population screening. J Med Screen 7:127, 2000
200. Gallas PR, Stolk RP, Bakker K, et al: Thyroid dysfunction during pregnancy and in the first postpartum year in women with diabetes mellitus type 1. Europ J Endocrinol 147:443, 2002
201. Jovanovic-Peterson I, Peterson CM: De novo clinical hypothyroidism in pregnancies complicated by type I diabetes. Am J Obstet Gynecol 159:442-446, 1988
202.Caturegli P, Newschaffer C, Olivi A, et al: Autoimmune hypophysitis. Endocr Rev 26:599, 2005
203. Ginsberg J, Walfish PG, Rafter DJ, et al: Thyrotrophin blocking antibodies in the sera of mothers with congenitally hypothyroid infants. Clin Endocrinol 25:189, 1986
204. Bogner U, Grüters A, Sigle B, et al: Cytotoxic antibodies in congenital hypothyroidism. J Clin Endocrinol Metab 68:671, 1989
205. Tamaki H, Amino N, Aozasa M, et al: Effective method for prediction of transient hypothyroidism in neonates born to mothers with chronic thyroiditis. Am J Perinatol 6:296, 1989
206. Brown RS, Keating P, Mitchell E: Maternal thyroid-blocking immunoglobulins in congenital hypothyroidism. J Clin Endocrinol Meteb 70:1341, 1990
207. Ueta Y, Fukui H, Murakami H, et al: Development of primary hypothyroidism with the appearance of blocking-type antibody to thyrotropin receptor in Graves’ disease in late pregnancy. Thyroid 9:179, 1999
208. Glinoer D: Management of hypo- and hyperthyroidism during pregnancy. Growth Hormone & IGF Research 13:45, 2003
209. Mandel SJ: Hypothyroidism and chronic autoimmune thyroiditis in the pregnant state: maternal aspects. In: Best Practice & Research in Clinical Endocrinology and Metabolism: The Thyroid and Pregnancy (Editor: Glinoer D) 18:213, 2004
210. Spong CY: Subclinical hypothyroidism: should all pregnant women be screened? (Editorial) Obstet Gynecol 105:237, 2005
211. Klintschar M, Schwaiger P, Mannweiler S, et al: Evidence of fetal microchimerism in Hashimoto’s thyroiditis. J Clin Endocrinol Metab 86:2494, 2001
212. Ando T, Imaizumi M, Graves P, et al: Intrathyroidal fetal microchimerism in Graves’ disease. J Clin Endocrinol Metab 87:3315, 2002
213. Imaizumi M, Pritsker A, Unger P, Davies TF: Intrathyroidal fetal microchimerism in pregnancy and postpartum. Endocrinology 143:247, 2002
214. Ando T, Davies TF: Self-recognition and the role of fetal microchimerism. In: Best Practice & Research in Clinical Endocrinology and Metabolism: The Thyroid and Pregnancy (Editor: Glinoer D) 18:197, 2004
215. Renné C, Ramos Lopez E, Steimle-Grauer SA, et al: Thyroid fetal male microchimerisms in mothers with thyroid disorders: presence of Y-chromosome immunofluorescence in thyroid-infiltrating lymphocytes is more prevalent in Hashimoto’s thyroiditis and Graves’ disease than in follicular adenomas. J Clin Endocrinol Metab 89:5810, 2004
216.Walsh JP, Bremmer AP, Bulsara MK, et al: Parity and the risk of autoimmune thyroid disease: a community-based study. J Clin Endocrinol Metab 90:5309, 2005
217.Pedersen IB, Laurberg P, Knudesen N, et al: Lack of association between thyroid autoantibodies and parity in a population study argues against microchimerism as a trigger of thyroid autoimmunity. Eur J Endocrinol 154:39, 2006
218.Thomas R, Reid RL: Thyroid disease and reproductive failure. Obstet Gynecol 70:789, 1987
219. Bakimer R, Cohen JR, Shoenfeld Y: What really happens to fecundity in autoimmune diseases? Immunol Allergy Clin N Am 14:701, 1994
220. Garber J: Thyroid disorders and reproduction. In: Infertility: A Comprehensive Text. Seibel M (Editor), Stanford, Appleton & Lange, pp 171-185, 1997
221. Krassas GE, Pontikides N, Kaltsas T, et al: Disturbances of menstruation in hypothyroidism. Clin Endocrinol 50:655, 1999
222. Krassas GE: Thyroid disease and female reproduction. Fertil Steril 74:1063, 2000
223. Abalovich M, Gutierrez S, Alcaraz G, et al: Overt and subclinical hypothyroidism complicating pregnancy. Thyroid 12:63, 2002
224. Davis LE, Leveno KJ, Cunningham FG: Hypothyroidism complicating pregnancy. Obstet Gynecol 72:108, 1988
225. Leung AS, Millar LK, Koonings PP, et al: Perinatal outcome in hypothyroid pregnancies. Obstet Gynecol 81:349, 1993
226. Mizgala L, Lao TT, Hannah ME: Hypothyroidism presenting as hypothermia following pre-eclampsia at 23 weeks gestation: case report and review of the literature. Br J Obstet Gynaecol 98:221, 1991
227. Wasserstrum N, Anania CA: Perinatal consequences of maternal hypothyroidism in early pregnancy and inadequate replacement. Clin Endocrinol 42:353, 1995
228. Casey BM, Dashe JS, Wells E, et al: Subclinical hypothyroidism and pregnancy outcome. Obstet Gynecol 105:239, 2005
229. Idris I, Srinivasan R, Simm A, Page RC: Maternal hypothyroidism in early and late gestation: effects on neonatal and obstetric outcome. Clin Endocrinol 63:560, 2005
230. Pop VJ, Brouwers EP, Wijnen H, et al: Low concentrations of maternal thyroxin during early gestation: a risk factor of breech presentation? Int J Obstet Gynaecol 111:925, 2004
231. Blazer S, Moreh-Waterman Y, Miller-Lotan R, et al: Maternal hypothyroidism may affect fetal growth and neonatal thyroid function. Obstet Gynecol 102:232, 2003
232. Montoro M, Collea JV, Frasier SD, Mestman JH: Successful outcome of pregnancy in women with hypothyroidism. Ann Intern Med 94:31, 1981
233. Liu H, Momotani N, Noh JY, et al: Maternal hypothyroidism during early pregnancy and intellectual development of progeny. Arch Intern Med 154:785, 1994
234.Tan TO, Cheng YW, Caughey AB: Are women who are treated for hypothyroidism at risk for pregnancy complications? Am J Obstet Gynecol 194:e1, 2006
235.Stagnaro-Green A, Chen X, Bogden JD, Davies TF, Scholl TO: The thyroid and pregnancy: a novel risk factor for very preterm delivery. Thyroid 15:351, 2005
236.Spong CY: Maternal thyroid disorders and preterm birth: another piece of the puzzle? (Editorial) Thyroid 15:349, 2005
237. Pop VJ, Kuijpens JL, Van Baar AL, et al: Low maternal free thyroxine concentrations during early pregnancy are associated with impaired psychomotor development in early infancy. Clin Endocrinol 50:149, 1999
238. Pop VJ, Brouwers EP, Vader HL, et al: Maternal hypothyroxinaemia during early pregnancy and subsequent child development: a 3-year follow-up study. Clin Endocrinol 59:282, 2003
239. Rotondi M, Caccavale C, Di Serio C, et al: Successful outcome of pregnancy in a thyroidectomized-parathyroidectomized young woman affected by severe hypothyroidism. Thyroid 9:1037, 1999
240. Kamijo K, Saito T, Yachi A, et al: Transient subclinical hypothyroidism in early pregnancy. Endocrinol Japon 37:397, 1990
241. Matsuura N, Konishi J and the transient hypothyroidism study group in Japan: Transient hypothyroidism in infants born to mothers with chronic thyroiditis - A nationwide study of twenty-three cases. Endocrinol Japon 37:369, 1990
242. Brent GA: Maternal hypothyroidism: recognition and management. Thyroid 9: 661, 1999
243. Arafah BM: Increased need for thyroxine in women with hypothyroidism during estrogen therapy. New Engl J Med 344:1743, 2001
244. Rotondi M, Mazziotti G, Sorvillo F, et al: Effects of increased thyroxine dosage pre-conception on thyroid function during early pregnancy. Eur J Endocrinol 151:695, 2004
245.Rotondi M, Precerutti S, Chiovato L: Maternal hypothyroidism during pregnancy: possible preventive strategies. Clin Endocrinol 64:596, 2006
246. Alexander EK, Marqusee E, Lawrence J, et al: timing and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidism. N Engl J Med 351:249, 2004
247. Caixas A, Albareda M, Garcia-Patterson A, et al: Postpartum thyroiditis in women with hypothyroidism antedating pregnancy. J Clin Endocrinol Metab 84:4000, 1999
248. Dowling ALS, Iannacone EA, Zoeller RT. Maternal hypothyroidism of neuroendocrine-specific protein A messenger ribonucleic acid in the proliferative zone of fetal rat brain cortex. Endocrinology 142:390, 2001
249. Iskaros J, Pickard M, Evans I, et al. Thyroid hormone receptor gene expression in first trimester human fetal brain. J Clin Endocrinol Metab 85:2620, 2000
250. Liu Y-Y, Tachiki KH, Brent GA: A targeted thyroid hormone receptor gene dominant-negative mutation (P398H) selectively impairs gene expression in differentiated embryonic stem cells. Endocrinology 143:2664, 2002
251. Kilby MD, Gittoes N, McCabe C, et al: Expression of thyroid receptor isoform in the human fetal central nervous system and the effects of intrauterine growth restriction. Clin Endocrinol 53:469, 2000
252.Koibuchi N, Iwasaki T: Regulation of brain development by thyroid hormones and its modulation by environmental chemicals. Endocrol J 53:295, 2006
253.Bernal J: Thyroid hormone receptors in brain development and function. Nature Clin Pract 3:249, 2007
254. Porterfield SP, Hendrich CE: The role of thyroid hormones in prenatal and neonatal neurological development: Current perspectives. Endocr Rev 14:94, 1993
255. Smallridge RC, Ladenson PW: Hypothyroidism in pregnancy: consequences to neonatal health. J Clin Endocrinol Metab 86:2349, 2001
256. Morreale de Escobar G, Obregon MJ, Escobar del Rey F: Maternal thyroid hormones early in pregnancy and fetal brain development. In: Best Practice & Research in Clinical Endocrinology and Metabolism: The Thyroid and Pregnancy (Editor: Glinoer D) 18:225, 2004
257. Lavado-Autric R, Auso E, Garcia-Velasco JV, et al: Early maternal hypothyroxinemia alters histogenesis and cerebral cortex cytoarchitecture of the progeny. J Clin Invest 111:1073, 2003
258. Zoeller RT: Transplacental thyroxine and fetal brain development. J Clin Invest 111:954, 2003
259.Dubois GM, Sebillot A, Kuiper GG, et al: Deiodinase activity is present in Xenopus laevis during early embryogenesis. Endocrinology 147:4941, 2006
260. Man EB, Jones WS, Holden RH, Mellits ED: Thyroid function in human pregnancy. VIII. Retardation of progeny aged 7 years; relationships to maternal age and maternal thyroid function. Amer J Obstet Gynecol 111:905, 1971
261. Man EB, Brown JF, Serunian SA: Maternal hypothyroidism: Psychoneurological deficits of progeny. Ann Clin Lab Ser 21:227, 1991
262. Mitchell ML, Klein RZ: The sequelae of untreated maternal hypothyroidism. Eur J Endocrinol 151:45, 2004
263. Haddow JE, Palomaki GE, Allan WC, et al: Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med 341:549, 1999
264. Rovet J: Neurodevelopmental consequences of maternal hypothyroidism during pregnancy (Abstract). Thyroid 14:710, 2004
265.Kooistra L, Crawford S, van Baar AL, et al: Neonatal effects of maternal hypothyroxinemia during early pregnancy. Pediatrics 117:161, 2006
266.Casey BM, Dashe JS, Spong CY, et al: Perinatal significance of isolated maternal hypothyroxinemia identified in the first half of pregnancy. Obstet Gynecol 109:1129, 2007
267. Mitchell ML, Klein RZ, Sargent JD, et al: Iodine sufficiency and measurements of thyroid function in maternal hypothyroidism. Clin Endocrinol 58:612, 2003
268. Bleichrodt N, Bjorn MP: A meta-analysis of research on iodine and its relationship to cognitive development. In: The damaged brain of iodine deficiency: cognitive, behavioral, neuromotor, educative aspects (Editor: Stanbury JB). Cognizant Communication Corporation; New York-Sydney-Tokyo, pp 195-200, 1994
269. Bleichrodt N, Escobar del Rey F, Morreale de Escobar G, et al: Iodine deficiency - Implications for mental and psychomotor development in children. In: Iodine and the Brain (Editors: DeLong GR, Robbins G, Condliffe PG). Plenum Press, New York, 269, 1989
270. Vermiglio F, Sidoti M, Finocchiaro MD, et al: Defective neuromotor and cognitive ability in iodine-deficient schoolchildren of an endemic goiter region in Sicily. J Clin Endocrinol Metab 70:379, 1990
271. Fenzi GF, Giusti LF, Aghini-Lombardi F, et al: Neuropsychological assessment in schoolchildren from an area of moderate iodine deficiency. J Endocrinol Invest 13:427, 1990
272. Vitti P, Aghini-Lombardi F, Antonangeli L, et al: Mild iodine deficiency in fetal/neonatal life and neuro-psychological performances. Acta Med Austr 19:57, 1992
273. Aghini-Lombardi F, Pinchera A, Antonangeli L, et al: Mild iodine deficiency during fetal/neonatal life and neuropsychological impairment in Tuscany. J Endocrinol Invest 18:57, 1995
274. Tiwari BD, Godbole MM, Chattopadhyay N, et al: Learning disabilities and poor motivation to achieve due to prolonged iodine deficiency. Am J Clin Nutr 63:782, 1996
275. Azizi F, Sarshar A, Nafarabadi M, et al: Impairment of neuromotor and cognitive development in iodine-deficient schoolchildren with normal physical growth. Acta Endocrinol 129:501, 1993
276. Vermiglio F, Lo Presti P, Moleti M, et al: Attention deficit and hyperactivity disorders on the offspring of mothers exposed to mild-moderate iodine deficiency: a possible novel iodine deficiency disorder in developed countries. J Clin Endocrinol Metab 89:6054, 2004
277. Becks GP, Burrow GN: Thyroid disease and pregnancy. Med Clin N Amer 75:121, 1991
278. Wang C, Crapo LM: The epidemiology of thyroid disease and implications for screening. Endocrinol Clin N Amer 26:189, 1997
279. LeBeau SO, Mandel SJ: Thyroid disorders during pregnancy. Endocrinol Metab Clin N Am 35:117, 2006
280. Hollowell JG, Staehling NW, Flanders WD, et al: Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 87:489, 2002
281. Hershman JM: Hyperthyroidism induced by trophoblastic thyrotropin. Mayo Clin Proc 47:913, 1997
282. Narasimhan KL, Ghobrial MW, Ruby EB: Hyperthyroidism in the setting of gestational trophoblastic disease. Amer J Med Sci 323:285, 2002
283. Coughlin L, Haddad: Struma ovarii presenting as hyperemesis gravidarum in pregnancy. J Obstet Gynecol 20:310, 2000
284. Ginsberg J, Lewanczuk RZ, Honore LH: Hyperplacentosis: a novel cause of hyperthyroidism. Thyroid 11:393, 2001
285. Mestman JH: Hyperthyroidism in pregnancy. In: Best Practice & Research in Clinical Endocrinology and Metabolism: The Thyroid and Pregnancy (Editor: Glinoer D) 18:267, 2004
286. Mestman JH: Hyperthyroidism in pregnancy. Clin Obstet Gynecol 40:45, 1997
287. Amino N, Tanizawa O, Mori H, et al: Aggravation of thyrotoxicosis in early pregnancy and after delivery in Graves' disease. J Clin Endocrinol Metab 55:108, 1982
288. Millar LK, Wing DA, Leung As, et al: Low birth weight and preeclampsia in pregnancies complicated by hyperthyroidism. Obstet Gynecol 84:946, 1994
289. Davis LE, Lucas MJ, Hankins GD, et al: Thyrotoxicosis complicating pregnancy. Am J Obstet Gynecol 160:63, 1989
290. Phoojaroenchanachai M, Sriussadaporn S, Peerapatdit T, et al: Effect of maternal hyperthyroidism during late pregnancy on the risk of neonatal low birth weight. Clin Endocrinol 54:365, 2001
291. Anselmo J, Cao D, Karrison T, Weiss RE, Refetoff S: Fetal loss associated with excess of thyroid hormone exposure. JAMA 292:691, 2004
292. Sheffield JS, Cunningham FG: Thyrotoxicosis and heart failure that complicate pregnancy. Am J Obstet Gynecol 190:211, 2004
293. Smith C, Thomsett, Choong C, et al: Congenital thyrotoxicosis in premature infants. Clin Endocrinol 54:371, 2001
294. Vaidya B, Campbell V, Tripp JH, et al: Premature birth and low birth weight associated with non-autoimmune hyperthyroidism due to an activating thyrotropin receptor gene mutation. Clin Endocrinol 60:711, 2004
295. Mitsuda N, Tamaki H, Amino N, et al: Risk factors for developmental disorders in infants born to women with Graves' disease. Obstet Gynecol 80:359, 1992
296. Laurberg P, Nygaard B, Glinoer D, et al: Guidelines for TSH-receptor antibody measurements in pregnancy: Results of an evidence-based symposium organized by the European Thyroid Association. Eur J Endocrinol 139:584, 1998
297. Radetti G, Persani L, Moroder W, et al: Transplacental passage of anti-thyroid auto-antibodies in a pregnant woman with auto-immune thyroid disease. Prenatal Diagnosis 19:468, 1999
298. Peleg D, Cada S, Ben-Ami M: The relationship between maternal serum thyroid-stimulating immunoglobulins and fetal and neonatal thyrotoxicosis. Obstet Gynecol 99:1040, 2002
299. Geva E, Amit A, Lerner-Geva L, Lessing JB: Autoimmunity and reproduction. Fertil Steril 67:599, 1997
300. Jones BM, Kwok JSY, Kung AWC: Changes in cytokine production during pregnancy in patients with Graves’ disease. Thyroid 10:701, 2000
301. Kung AWC, Jones BM: A change from stimulatory to blocking antibody activity in Graves' disease during pregnancy. J Clin Endocrinol Metab 83:514, 1998
302. Kung AWC, Lau KS, Kohn LD: Epitope mapping of TSH receptor-blocking antibodies in Graves’ disease that appear during pregnancy. J Clin Endocrinol Metab 86:3647, 2001
303. Amino N, Izumi Y, Hidaka Y, et al: No increase of blocking type anti-thyrotropin receptor antibodies during pregnancy in patients with Graves’ disease. J Clin Endocrinol Metab 88:5871, 2003
304.Gola S, Doga M, Mazziotti G, Bonadonna S, Giustina A: Development of Graves’ hyperthyroidism during the early phase of pregnancy in a patient with pre-existing and long-standing Hashimoto’s hypothyroidism. J Endocrinol Invest 29:288, 2006
305. Mandel SJ, Cooper DS: The use of antithyroid drugs in pregnancy and lactation. J Clin Endocrinol Metab 86:2354, 2001
306. Cooper DS: Antithyroid drugs. N Engl J Med 352:905, 2005
307. Wing DA, Millar LK, Koonings PP, et al: A comparison of propylthiouracil versus methimazole in the treatment of hyperthyroidism in pregnancy. Am J Obstet Gynecol 170:90, 1994
308. Mandel SJ, Brent GA, Larsen PR: Review of antithyroid drug use during pregnancy and report of a case of aplasia cutis. Thyroid 4:129, 1994
309. Marchant B, Brownlie BEW, Hart DM, et al: The placental transfer of propylthiouracil, methimazole and carbimazole. J Clin Endocrinol Metab 45:1187, 1977
310. Skellern CG, Knight BI, Otter M: The pharmacokinetics of methimazole in pregnant patients after oral administration of carbimazole. Brit J Clin Pharmacol 9:145, 1980
311. Gardner DF, Cruikshank DP, Hays PM, Cooper DS: Pharmacology of propylthiouracil (PTU) in pregnant hyperthyroid women: Correlation of maternal PTU concentration with cord serum thyroid function tests. J Clin Endocrinol Metab 62:217, 1986
312. Cheron RG, Kaplan MM, Larsen PR, et al: Neonatal thyroid function after propylthiouracil therapy for maternal Graves’ disease. N Engl J Med 304:525, 1981
313. Mortimer R, Cannell GR, Addison R, et al: Methimazole and propylthiouracil equally cross the perfused human term placental lobule. J Clin Endocrinol Metab 82:3099, 1997
314. Momotani N, Noh JY, Ishikawa N, Ito K: Effects of propylthiouracil (PTU) and methimazole (MMI) on fetal thyroid status in mothers with Graves’ hyperthyroidism. J Clin Endocrinol Metab 82:3633, 1997
315. Klasco RK (Edition 2005); REPROTOX database Greenwood Village, CO: Thomson Micromedex. Available at: http://www.thomsonhc.com
316.Redmond GP: Propranolol and fetal growth retardation. Semin Perinatol 6:142, 1982
317.Herbst AL, Selenkow HA: Hyperthyroidism during pregnancy. N Engl J Med 273:627, 1965
318. Momotani N, Hisaoka T, Noh J, et al: Effects of iodine on thyroid status of fetus versus mother in treatment of Graves’ disease complicated by pregnancy. J Clin Endocrinol Metab 75:738, 1992
319. Zanzonico PB: Radiation dose to patients and relatives incident to 131-I therapy. Thyroid 7:199, 1997
320. Berg GE, Nystrom EH, Jacobsson L, et al: Radioiodine treatment of hyperthyroidism in a pregnant woman. J Nucl Med 39:2194, 1998
321. Lowe SA: Diagnostic radiography in pregnancy: risks and reality. Aust NZ J Obstet Gynaecol 44:191, 2004
322.Levinson G: Anesthesia for surgery during pregnancy. In: Hughes SC, Levinson G, Rosen MA (Eds). Shnider & Levinson's anesthesia for obstetrics, 4th ed. Philadelphia; Lippincott Williams & Wilkins; pp 249-265, 2002
323. Low LC, Lang J, Alexander WD: Excretion of carbimazole and propylthiouracil in breast milk. Lancet 2:1011, 1979
324. Kampmann JP, Johansen K, Hansen JM, Helweg J: Propylthiouracil in human milk. Lancet 1:736, 1980
325. Tegler L, Lindstrom B: Antithyroid drugs in milk. Lancet 2:591, 1980
326. Lamberg BA, Ikonen E, Teramo K, et al: Treatment of maternal hyperthyroidism with antithyroid agents and changes in thyrotrophin and thyroxin in the newborn. Acta Endocrinol 97:186, 1981
327. Lamberg BA, Ikonen E, Osterlund K, et al: Antithyroid drug treatment of maternal hyperthyroidism during lactation. Clin Endocrinol 21:81, 1984
328. Azizi F, Khoshniat M, Bahrainian M, Hedayati M: Thyroid function and intellectual development of infants nursed by mothers taking methimazole. J Clin Endocrinol Metab 85:3233, 2000
329. Mestman JH: Hyperthyroidism in pregnancy. Endocrinol Clin N Amer 27:127, 1998
330. Azizi F: Thyroid function in breast-fed infants is not affected by methimazole-induced maternal hypothyroidism: results of a retrospective study. J Endocrinol Invest 26:301-304, 2003
331. Rapoport B, Chazenbalk GD, Jaume JC, McLachlan SM: The thyrotropin (TSH)-releasing hormone receptor: interaction with TSH and autoantibodies. Endocrine Rev 19:673, 1998
332. Matsuura N, Harada S, Ohyama Y, et al: The mechanisms of transient hypothyroxinemia in infants born to mothers with Graves’ disease. Ped Res 42:214, 1997
333. Weetman AP: Graves’ disease. New Eng J Med 343:1236, 2000
334. Nachum Z, Rakover Y, Weiner E, Shalev E: Graves’ disease in pregnancy: prospective evaluation of a selective invasive treatment protocol. Am J Obstet Gynecol 189:159, 2003
335. Polak M: Hyperthyroidism in early infancy: Pathogenesis, clinical features and diagnosis with a focus on neonatal hyperthyroidism. Thyroid 8:1171, 1998
336. Porreco RP, Bloch CA: Fetal blood sampling in the management of intrauterine thyrotoxicosis. Obstet Gynecol 76:509, 1990
337. Thorpe-Beeston JG, Nicolaides KH, Felton CV, et al: Maturation of the secretion of thyroid hormone and thyroid-stimulating hormone in the fetus. New Engl J Med 324:532, 1991
338. Wallace C, Couch R, Ginsberg J: Fetal thyrotoxicosis: a case report and recommendations for prediction, diagnosis, and treatment. Thyroid 5:125, 1995
339. Skuza KA, Sills IN, Stene M, Rapaport R: Prediction of neonatal hyperthyroidism in infants born to mothers with Graves’ disease. J Pediat 128:264, 1996
340. Polak M, Leger J, Luton D, et al: Fetal cord blood sampling in the diagnosis and treatment of fetal hyperthyroidism in the offsprings of a euthyroid mother producing thyroid stimulating antibodies. Ann Endocrinol (Paris) 58:338, 1997
341. Momotani N, Noh J, Oyanagi H, et al: Antithyroid drug therapy for Graves’ disease during pregnancy: optimal regimen for fetal thyroid status. N Eng J Med 315:24, 1986
342. Azizi F, Khamseh ME, Bahreynian M, Hedayati M: Thyroid function and intellectual development of children of mothers taking methimazole during pregnancy. J Endocrinol Invest 25:586, 2002
343. Calderwood C, Williams H, Campbell IW, et al: Cordocentesis to predict fetal outcome after administration of radio-active iodine for Graves’ disease. J Obstet Gynaecol 22:217, 2002
344.Wenstrom KD, Weiner CP, Williamson RA, Grant SS: Prenatal diagnosis of fetal hyperthyroidism using funipuncture. Obstet Gynecol 76:513, 1990
345.Azizi F, Hedayati M: Thyroid function in breast-fed infants whose mothers take high doses of methimazole. J Endocrinol Invest 25:493, 2002
346.Casey BM, Dashe JS, Wells CE, et al: Subclinical hyperthyroidism and pregnancy outcomes. Obstet Gynecol 107:337, 2006
347. Davidson KM, Richards DS, Schatz DA, Fisher DA: Successful in utero treatment of fetal goiter and hypothyroidism. New Eng J Med 324:543, 1991
348. Heckel S, Favre R, Schlienger JL, Soskin P: Diagnosis and successful in utero treatment of a fetal goitrous hyperthyroidism caused by maternal Graves’ disease. Fetal Diagn Ther 12:54, 1997
349. Ochoa-Maya MR, Frates MC, Lee-Parritz A, Seely EW: Resolution of fetal goiter after discontinuation of propylthiouracil in a pregnant woman with Graves’ hyperthyroidism. Thyroid 9:1111, 1999
350. Volumenie JL, Polak M, Guibourdenche J, et al: Management of fetal goitres: a report of eleven cases in a single perinatal unit. Prenat Diagn 20:799, 2000
351. Polak M, Le Gac I, Vuillard E, et al: Fetal and neonatal thyroid function in relation to maternal Graves’ disease. In: Best Practice & Research in Clinical Endocrinology and Metabolism: The Thyroid and Pregnancy (Editor: Glinoer D) 18:289, 2004
352. Luton D, Le Gac I, Vuillard E, et al: Management of Graves’ disease during pregnancy: the key role of fetal thyroid gland monitoring. J Clin Endocrinol Metab 90:6093, 2005
353. Gallagher MP, Schachner HC, Levine LS, et al: Neonatal thyroid enlargement associated with propylthiouracil therapy of Graves’ disease during pregnancy: a problem revisited. J Pediatr 139:896, 2001
354.Luton D, Le Gac I, Noel M, Guibourdenche J, Polak M: Thyroid function during pregnancy in women with past Graves’ disease. Brit J Obstet Gynaecol 112:1565, 2005
355. Frieden IJ: Aplasia cutis congenita: a clinical review and proposal for classification. Acta Dermatol 14:646, 1986
356. Clementi M, Di Gianantonio E, Pelo E, et al: Methimazole embryopathy: delineation of the phenotype. Am J Med Genet 83:43, 1999
357. Johnsson E, Larsson G, Ljunggren M: Severe malformations in infant born to hyperthyroid woman on methimazole. Lancet 350:1520, 1997
358. Bournaud C, Orgiazzi J: Embryopathies et anti-thyroïdiens. Ann Endocrinol (Paris) 64:366, 2003
359. Di Gianantonio E, Schaefer C, Mastroiacovo P, et al: Adverse effects of prenatal methimazole exposure. Teratology 64:262, 2001
360. Zakarija M, Garcia A, McKenzie JM: Studies on multiple thyroid cell membrane-directed antibodies in Graves’ disease. J Clin Endocrinol Metab 76:1885, 1985
361. Tamaki H, Amino N, Aozasa M, et al: Universal predictive criteria for neonatal overt thyrotoxicosis requiring treatment. Am J Perinatol 5:152, 1988
362.Polak M, Legac I, Vuillard E, Guibourdenche J, Castanet M, Luton D: Congenital hyperthyroidism: the fetus as a patient. Horm Res 65:235, 2006
363. Mandel SH, Hanna CE, LaFranchi SH: Neonatal hypopituitarism associated with maternal thyrotoxicosis. J Pediat Endocrinol 3:189, 1989
364. Kempers MJ, van Tijn DA, van Trotsenburg AS, et al: Central congenital hypothyroidism due to gestational hyperthyroidism: detection where prevention failed. J Clin Endocrinol Metab 88:5851, 2003
365. Stagnaro-Green A: Postpartum thyroiditis (Clinical Review N° 152). J Clin Endocrinol Metab 87:4042, 2002
366. Amino N, Tada H, Hidaka Y, Izumi Y: Postpartum autoimmune thyroid syndrome. Endocr J 47 :645, 2000
367. Sakaihara M, Yamada H, Kato EH, et al: Postpartum thyroid dysfunction in women with normal thyroid function during pregnancy. Clin Endocrinol 53:487, 2000
368. Stagnaro-Green A: Postpartum thyroiditis. In: Best Practice & Research in Clinical Endocrinology and Metabolism: The Thyroid and Pregnancy (Editor: Glinoer D) 18:303, 2004
369. Premawardhana LD, Parkes AB, Ammari F, et al: Postpartum thyroiditis and long-term thyroid status: prognostic influence of thyroid peroxidase antibodies and ultrasound echogenicity. J Clin Endocrinol Metab 85:71, 2000
370. Premawardhana LD, Parkes AB, John R, Harris B, Lazarus JH: Thyroid peroxidase antibodies in early pregnancy: utility for prediction of postpartum thyroid dysfunction and implications for screening. Thyroid 14:610, 2004
371. Hidaka Y, Tamaki H, Iwatani Y, et al: Prediction of post-partum Graves’ thyrotoxicosis by measurement of thyroid stimulating antibody in early pregnancy. Clin Endocrinol 41:15, 1994
372. Nakagawa Y, Mori K, Hoshikawa S, Yamamoto M, et al: Postpartum recurrence of Graves’ hyperthyroidism can be prevented by the continuation of antithyroid drugs during pregnancy. Clin Endocrinol 57:467, 2002
373. Benhaim Rochester D, Davies TF: Increased risk of Graves’ disease after pregnancy. Thyroid 15:1287, 2005
374. Leylek OA, Cetin A, Toyaksi M, Erselcan T: Hyperthyroidism in hyperemesis gravidarum. Int J Gynaecol Obstet 55:33, 1996
375. Tanaka S, Yamada H, Kato EH, et al: Gestational transient hyperthyroxinaemia (GTH): screening for thyroid function in 23163 pregnant women using dried blood spots. Clin Endocrinol 49:325, 1998
376. Yeo CP, Hsu Chin Khoo D, Hsi Ko Eng P, et al: Prevalence of gestational thyrotoxicosis in Asian women evaluated in the 8th to 14th weeks of pregnancy: correlations with total and free beta human chorionic gonadotrophin. Clin Endocrinol 55:391, 2001
377. Ramsey PS, Ramin KD: 34-year-old pregnant woman with nausea and vomiting. May Clin Proc 75:1317, 2000
378. Utiger RD: Some women with hyperemesis gravidarum have transient hyperthyroidism. Clinical Thyroidology 14:56, 2002
379. Anselmo J, Kay T, Dennis K, et al: Resistance to thyroid hormone does not abrogate the transient thyrotoxicosis associated with gestation: report of a case. J Clin Endocrinol Metab 86:4273, 2001
380. Grün JP, Meuris S, De Nayer P, Glinoer D: The thyrotropic role of human chorionic gonadotropin (hCG) in the early stages of twin (versus single) pregnancy. Clin Endocrinol 46:719, 1997
381. Kimura M, Amino N, Tamaki H, et al: Gestational thyrotoxicosis and hyperemesis gravidarum: possible role of hCG with higher stimulating activity. Clin Endocrinol 38:345, 1993
382. Tsuruta E, Tada H, Tamaki H, et al: Pathogenic role of asialo human chorionic gonadotropin in gestational thyrotoxicosis. J Clin Endocrinol Metab 80:350, 1995
383. Talbot JA, Lambert A, Anobile CJ, et al: The nature of human chorionic gonadotrophin glycoforms in gestational thyrotoxicosis. Clin Endocrinol 55:33, 2001
384. Vassart G, Dumont JE: The thyrotropin receptor and the regulation of thyrocyte function and growth. Endocr Rev 13:596, 1992
385. Garcia-Campayo V, Kumar TR, Boime I: Thyrotropin, follitropin, and chorionic gonadotropin expressed as a single multifunctional unit reveal remarkable permissiveness in receptor-ligand interactions. Endocrinology 143:3773, 2002
386. Rodien P, Brémont C, Raffin Sanson M-L, et al: Familial gestational hyperthyroidism caused by a mutant thyrotropin receptor hypersensitive to human chorionic gonadotropin. New Engl J Med 339:1823, 1998
387. Rodien P: Un récepteur de la TSH hypersensible à l’hCG responsable d’une hyperthyroïdie gestationelle récidivante et familiale. Reproduction Humaine & Hormones 14:655, 2001
388. Rodien P, Jordan N, Lefèvre A, et al: Abnormal stimulation of the thyrotrophin receptor during gestation. Hum Reprod Update 10:95, 2004
389. Deruelle P, Dufour P, Subtil D, et al: Hyperemesis in the first trimester of pregnancy: role of biological hyperthyroidism and fetal sex. Gynecol Obstet Fertil 30:204, 2002
390. Panesar NS, Li C-Y, Rogers MS: Are thyroid hormones or hCG responsible for hyperemesis gravidarum ? A matched paired study in pregnant Chinese women. Acta Obstet Gynecol Scand 80:519, 2001
391. Rosen IB, Walfish PG, Nikore V: Pregnancy and surgical thyroid disease. Surgery 98:1135, 1985
392. Hamburger JI: Thyroid nodules in pregnancy. Thyroid 2:165, 1992
393. Struve C, Haupt S, Ohlen S: Influence of frequency of previous pregnancies on the prevalence of thyroid nodules in women without clinical evidence of thyroid disease. Thyroid 3:7, 1993
394. Kung AWC, Chau MT, Lao TT, Tam SCF, Low LCK: The effect of pregnancy on thyroid nodule formation. J Clin Endocrinol Metab 87:1010, 2002
395. Choe W, McDougall IR: Thyroid cancer in pregnant women: diagnosis and therapeutic management. Thyroid 4:433, 1994
396. Mazzaferri EL, Jhiang SM: Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97:418, 1994
397. Moosa M, Mazzaferri EL: Outcome of differentiated thyroid cancer diagnosed in pregnant women. J Clin Endocrinol Metab 82:2862, 1997
398. Glinoer D: Nodule et cancer thyroïdiens chez la femme enceinte. Annales d’Endocrinologie (Paris) 58:263, 1997
399. Rosen IB, Korman M, Walfish PG: Thyroid nodular disease in pregnancy: current diagnosis and management. Clin Obstet Gynecol 40:81, 1997
400. Herzon FS, Morris DM, Segal MN, et al: Coexistent thyroid cancer and pregnancy. Arch Otolaryngol Head Neck Surg 120:1191, 1994
401. Sam S, Molitch ME: Timing and special concerns regarding endocrine surgery during pregnancy. Endocrinol Metab Clin N Am 32:337, 2003
402. Vini L, Hyer S, Pratt B, Harmer C: Management of differentiated thyroid cancer diagnosed during pregnancy. Eur J Endocrinol 140:404, 1999
403. Ruegemer JJ, Hay ID, Bergstralh EJ, Ryan JJ, Offord KP, Gorman CA: Distant metastases in differentiated thyroid carcinoma: a multivariate analysis of prognostic variables. J Clin Endocrinol Metab 67:501, 1988
404. Doherty C, Shindo M, Rice D, et al: Management of thyroid nodules during pregnancy. Laryngoscope 105:251, 1995
405. Tan GH et al: Management of thyroid nodules in pregnancy. Arch Int Med 156:2317, 1996
406. Yasmeen S, Cress R, Romano PS, et al: Thyroid cancer in pregnancy. Int J Gynaecol Obstet 91:15, 2005
407.Stagnaro-Green A: Can a high-risk case-finding approach identify all women with thyroid dysfunction during pregnancy. Nature Clin Pract 3:216, 2007
408.Lazarus JH, Premawardhana LD: Screening for thyroid disorders in pregnancy. J Clin Pathol 58:449, 2005
409.American College of Obstetricians & Gynecologists. ACOG practice bulletin (N°37): Clinical management guidelines for obstetricians-gynecologists. Obstet Gynecol 100:387, 2002
410. Ladenson PW, Singer PA, Ain KB, et al: American Thyroid Association guidelines for detection of thyroid dysfunction. Arch Intern Med 160:1573, 2000
411. Surks MI, Ortiz E, Daniels GH, et al: Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 291:228, 2004
412.Gharib H, Tuttle MR, Baskin HJ, et al: Consensus statement: Subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and The Endocrine Society. J Clin Endocrinol Metab 90:581, 2005
413. Haddow JE, McClain MR, Palomaki GE, et al: Screening for thyroid disorders during pregnancy: results of a survey in Maine. Am J Obstet Gynecol 194:471, 2006
414.Surks MI: Subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and the Endocrine Society. J Clin Endocrinol Metab 90:586, 2005
415. Vaidya B, Anthony S, Bilous M, et al: Detection of thyroid dysfunction in early pregnancy: universal screening or targeted high-risk case finding? J Clin Endocrinol Metab 92:203, 2007
416.Brent GA: Diagnosing thyroid dysfunction in pregnant women: is case finding enough (Editorial)? J Clin Endocrinol Metab 92:39, 2007